- $169.28m
- $210.24m
- $174.89m
- 41
- 48
- 70
- 52
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Total Revenue | 135 | 148 | 176 | 163 | 175 |
Losses, Benefits, and Adjustments | |||||
Amortization of Policy Acquisition Costs | |||||
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 156 | 175 | 194 | 187 | 188 |
Operating Profit | -20.5 | -27.5 | -17.3 | -23.6 | -13.5 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -20.2 | -27.3 | -17 | -22.6 | -10.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -19.3 | -25 | -16.7 | -20.5 | -9.89 |
Net Income Before Extraordinary Items | |||||
Net Income | -19.3 | -25 | -16.7 | -20.5 | -9.89 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -19.3 | -25 | -16.7 | -20.5 | -9.89 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.3 | -1.68 | -1.12 | -1.36 | -0.665 |
Special Dividends per Share |